D-0372-2019 Class I Terminated

Recalled by Sun Pharmaceutical Industries, Inc. — Cranbury, NJ

FDA drug recall D-0372-2019 was initiated by Sun Pharmaceutical Industries, Inc. on Jan 3, 2019 and is designated Class I. Reason for recall: Presence of Particulate Matter: Foreign matter identified as glass detected in Vecuronium Bromide for Injection. The recall status is terminated (terminated Nov 3, 2021). Affected quantity: 12,534 cartons, 125,340 vials.

Recall details

Product Type
Drugs
Report Date
Jan 16, 2019
Initiation Date
Jan 3, 2019
Termination Date
Nov 3, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
12,534 cartons, 125,340 vials

Product description

Vecuronium Bromide for Injection 10 mg*, *1mg/mL when reconstituted to 10 mL Lyophilized, 10 x 10 mg vials, Rx only, Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway Halol-389 350, Gujarat, India. Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 NDC 47335-931-40 [vial] NDC 47335-931-44 [carton]

Reason for recall

Presence of Particulate Matter: Foreign matter identified as glass detected in Vecuronium Bromide for Injection.

Distribution pattern

Nationwide in the USA

Code information

Lot #: JKS0443A, JKS0444A, JKS0477A, EXP 03/2019

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0372-2019
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0372-2019. Report a data issue: hello@regdatalab.com.